Report : A-Z HCD items in Formulary 03/07/2020 18:33:29

[Back]

Section Status BlueTeq Name 08.01.05 Formulary Abemaciclib tabs  08.03.04.02 Formulary Abiraterone tabs  11.99.99.99 Formulary Adalimumab injection uveitis 13.05.03 Formulary Adalimumab injection Hidradenitis suppurativa 08.01.05 Formulary Alectinib caps  08.02.03 Formulary Alemtuzumab injection multiple sclerosis 10.01.03 Formulary Anakinra injection Adult-Onset Still's Disease 08.01.05 Formulary Arsenic trioxide injection  08.01.05 Formulary Atezolizumab injection lung cancer indications 08.01.05 Formulary Atezolizumab injection urothelial cancer indications 08.01.05 Formulary Avelumab injection   08.01.05 Formulary Axicabtagene ciloleucel cells dispersion for infusion  05.01.09 Formulary Bedaquiline tabs Sirturo® 10.01.03 Restricted Use Belimumab injection  08.01.01 Formulary Bendamustine injection  03.04.02 Formulary Benralizumab injection  08.01.05 Formulary Bevacizumab injection licensed use 08.01.05 Formulary Binimetinib tabs  08.02.03 Formulary Blinatumomab injection  08.01.05 Formulary Bortezomib injection  02.05.01 Restricted Use Bosentan tabs digital ulcer disease - off-label 08.01.05 Formulary Bosutinib tabs  08.01.05 Formulary Brentuximab injection  08.01.05 Formulary Brigatinib tabs  03.04.03 Formulary C1 esterase inhibitor injection  08.01.05 Formulary Cabazitaxel injection  08.01.05 Formulary Cabozantinib caps Cometriq - thyroid cancer 08.01.05 Formulary Cabozantinib tablets Cabometyx - renal carcinoma 04.06 Formulary Cannabidiol solution Epidyolex 08.01.05 Formulary Carfilzomib injection   08.01.05 Formulary Cemiplimab injection   08.01.05 Formulary Ceritinib caps  08.01.05 Formulary Cetuximab injection colorectal cancer 08.01.05 Formulary Cetuximab injection head and neck cancer 01.09.01 Formulary Chenodeoxycholic acid capsules  01.09.01 Formulary Cholic acid capsules  08.02.04 Formulary Cladribine tabs multiple sclerosis 04.09.01 Formulary Co-careldopa intestinal gel Duodopa® 08.01.05 Formulary Crizotinib caps  08.01.03 Formulary Cytarabine and daunorubicin (liposomal) injection Vyxeos® 08.01.05 Formulary Dabrafenib caps  08.01.05 Formulary Dacomitinib caps  08.02.04 Formulary Daratumumab injection  08.01.05 Formulary Dasatinib tabs  02.08.01 Formulary Defibrotide infusion  05.01.09 Formulary Delamanid tabs Deltyba® 08.02.04 Formulary Dimethyl fumarate caps Tecfidera - multiple sclerosis 08.01.02 Formulary Doxorubicin hydrochloride pegylated liposomal injection  08.01.05 Formulary Durvalumab injection  09.01.03 Formulary Eculizumab injection Atypical Haemolytic Uraemic Syndrome [aHUS] 09.01.03 Restricted Use Eculizumab injection C3 glomerulopathy post-kidney transplant 09.01.03 Formulary Emicizumab injection  08.01.05 Formulary Encorafenib caps  05.03.03.02 Formulary Epclusa® tabs sofosbuvir and velpatasvir 08.01.05 Formulary Eribulin injection  09.05.01.02 Formulary Etelcalcetide injection  08.01.05 Formulary Everolimus tabs neuroendocrine tumours 08.01.05 Formulary Everolimus tabs seizures associated with tuberous sclerosis complex 08.01.05 Formulary Everolimus tabs breast cancer 08.01.05 Formulary Everolimus tabs renal cancer 08.02.04 Formulary Fingolimod caps  08.02.03 Formulary Gemtuzumab ozogamicin infusion  08.02.04 Formulary Glatiramer acetate injection  05.03.03.02 Formulary Harvoni® tabs sofosbuvir and ledipasvir 08.01.05 Formulary Ibrutinib caps  08.01.05 Formulary Inotuzumab ozogamicin injection  08.02.04 Formulary Interferon beta-1a injection multiple sclerosis 08.02.04 Formulary Interferon beta-1b injection multiple sclerosis 08.01.05 Formulary Ipilimumab injection  05.02.01 Formulary Isavuconazole tabs, injection  08.02.04 Formulary Ixazomib caps  03.04.03 Formulary Lanadelumab injection  08.02.04 Formulary Lenalidomide caps licensed use 08.01.05 Formulary Lenvatinib caps renal cancer - Kisplyx® 08.01.05 Formulary Lenvatinib caps hepatocellular carcinoma - Lenvima® 08.01.05 Formulary Lenvatinib caps thyroid cancer - Lenvima® 05.03.02.02 Formulary Letermovir tabs  08.01.05 Formulary Lutetium (177Lu) oxodotreotide injection  03.07 Formulary Mannitol inhalation powder Bronchitol® 05.03.03.02 Formulary Maviret® tabs glecaprevir and pibrentasvir 03.04.02 Formulary Mepolizumab injection  10.02.02 Formulary Mexiletine caps congenital myotonia 08.01.05 Formulary Midostaurin caps  08.02.04 Restricted Use Natalizumab injection  08.01.05 Formulary Neratinib tabs  08.01.05 Formulary Nilotinib caps  03.11 Formulary Nintedanib caps Ofev® - idiopathic pulmonary fibrosis 08.01.05 Formulary Niraparib caps  08.01.05 Formulary Nivolumab injection haematological cancer 08.01.05 Formulary Nivolumab injection skin cancer 08.01.05 Formulary Nivolumab injection lung, renal, head and neck and urothelial cancer 01.09.01 Formulary Obeticholic acid tabs  08.02.03 Formulary Obinutuzumab injection  08.02.04 Formulary Ocrelizumab injection  08.01.05 Formulary Olaparib tabs  03.04.02 Restricted Use Omalizumab injection asthma 08.01.05 Formulary Osimertinib tabs  08.01.05 Formulary Paclitaxel albumin injection Abraxane 08.01.05 Formulary Palbociclib tabs  08.01.05 Formulary Panitumumab injection  08.03.04.03 Formulary Pasireotide injection  08.02.04 Formulary Peginterferon beta-1a injection  06.05.01 Formulary Pegvisomant injection  08.01.05 Formulary Pembrolizumab injection lung cancer indications 08.01.05 Formulary Pembrolizumab injection skin cancer indications 08.01.05 Formulary Pembrolizumab injection urothelial cancer indications 08.01.05 Formulary Pembrolizumab injection Hodgkin lymphoma 08.01.03 Formulary Pemetrexed injection  08.01.05 Formulary Pertuzumab injection  03.11 Formulary Pirfenidone caps  09.01.07 Restricted Use Plerixafor injection  08.02.04 Formulary Pomalidomide caps  08.01.05 Formulary Ponatinib tabs  03.04.03 Formulary Recombinant C1 esterase inhibitor injection Ruconest, Conestat Alpha 08.01.05 Formulary Regorafenib tabs gastrointestinal stromal tumours 08.01.05 Formulary Regorafenib tabs hepatocellular carcinoma 03.04.02 Formulary Reslizumab injection  08.01.05 Formulary Ribociclib tabs  10.01.03 Formulary Rituximab injection ANCA vasculitis 10.01.03 Restricted Use Rituximab injection rheumatology - off-label indications 10.02.01 Formulary Rituximab injection myaesthenia gravis - off-label 13.05.03 Formulary Rituximab injection dermatology indications 08.02.03 Formulary Rituxmab injection anti-NMDAR autoimmune encephalitis - off-label 08.01.05 Formulary Rucaparib tabs  08.01.05 Formulary Sorafenib tablets Hepatocellular carcinoma 08.01.05 Formulary Sorafenib tablets thyroid cancer 08.01.05 Formulary Sunitinib caps neuroendocrine tumours 08.01.05 Formulary Talimogene laherparepvec injection  08.02.04 Formulary Teriflunomide tablets  08.01.05 Formulary Tisagenlecleucel cells dispersion for infusion  08.01.05 Formulary Tivozanib caps  10.01.03 Formulary Tocilizumab cytokine relsease syndrome following CAR T-cell therapy 10.01.03 Formulary Tocilizumab injection Adult-Onset Still's Disease 10.01.03 Formulary Tocilizumab subcutaneous injection giant cell arteritis 08.01.05 Formulary Trametinib tabs  08.01.05 Formulary Trastuzumab emtansine injection   09.08.01 Formulary Trientine dihydrochloride tabs  08.01.03 Formulary Trifluridine–tipiracil tablets  08.01.05 Formulary Venetoclax tabs  05.03.03.02 Formulary Vosevi® tabs sofosbuvir, velpatasvir and voxilaprevir 05.03.03.02 Formulary Zepatier® tabs elbasvir and grazoprevir

South East London Joint Medicines Formulary